Skip to content

Home
About us
– Studies
Events & Continuous Training
Resources
Contact us
EN
- DE

Home
About us
– Studies
Events & Continuous Training
Resources
Contact us
EN
- DE

STUDIES.

SCIENTIFIC RESEARCH
IN FOCUS.

State of the study:
Rekrutierend

Contact:
Prof. Dr. Maximilian Niyazi (Tübingen)

Art der Erkrankung:
Glioblastom

NOA-28/PRIDE

Protective VEGF inhibition for isotoxic dose escalation in glioblastoma.

Previous Study NOA-27

Next Study NOA-29/ATLAS

© NOA – NEUROONKOLOGISCHE ARBEITSGEMEINSCHAFT ©

– Legal Notice
– Privacy policy